Transgenics can substantially reduce capital investment and lower production costs through economies of scale and more flexible scale-up.
Nancy Markley
Advertisement
Nancy Markley, PhD is director of business development at SemBioSys Genetics Inc.
Articles by Nancy Markley
Advertisement
Latest Updated Articles
Producing Proteins Using Transgenic Oilbody-Oleosin TechnologyPublished: June 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
2
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
3
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
4
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
5
